These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay. Cheng JW, Charland SL, Shaw LM, Kobrin S, Goldfarb S, Stanek EJ, Spinler SA. Pharmacotherapy; 1997 Apr; 17(3):584-90. PubMed ID: 9165563 [Abstract] [Full Text] [Related]
3. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. O'Riordan S, Ouldred E, Brice S, Jackson SH, Swift CG. Br J Clin Pharmacol; 2002 Apr; 53(4):398-402. PubMed ID: 11966673 [Abstract] [Full Text] [Related]
8. Can digoxin dose requirements be predicted? Dobbs SM, Mawer GE, Rodgers M, Woodcock BG, Lucas SB. Br J Clin Pharmacol; 1976 Apr; 3(2):231-7. PubMed ID: 973957 [Abstract] [Full Text] [Related]
9. [Serum digoxin concentration: dependence on body weight and age]. Kaufmann G, Neumann P. Schweiz Med Wochenschr; 1977 Nov 26; 107(47):1695-9. PubMed ID: 929130 [Abstract] [Full Text] [Related]
10. Estimation of digoxin dosage in VLBW infants using serum creatinine concentrations. Gortner L, Hellenbrecht D. Acta Paediatr Scand; 1986 May 26; 75(3):433-8. PubMed ID: 3728003 [Abstract] [Full Text] [Related]
11. Steady-state kinetics of digoxin in the elderly. Roberts MA, Caird FI. Age Ageing; 1976 Nov 26; 5(4):214-23. PubMed ID: 1008007 [Abstract] [Full Text] [Related]
12. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense? el-Desoky ES, Madabushi R, Amry Sel-D, Bhattaram VA, Derendorf H. Am J Ther; 2005 Nov 26; 12(4):320-7. PubMed ID: 16041195 [Abstract] [Full Text] [Related]
13. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T. J Clin Pharmacol; 1997 Feb 26; 37(2):92-100. PubMed ID: 9055134 [Abstract] [Full Text] [Related]
14. Predictive performance of four pharmacokinetic methods for calculating digoxin dosage. el-Sayed YM. J Clin Pharm Ther; 1995 Oct 26; 20(5):297-304. PubMed ID: 8576297 [Abstract] [Full Text] [Related]
15. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. Okada RD, Hager WD, Graves PE, Mayersohn M, Perrier DG, Marcus FI. Circulation; 1978 Dec 26; 58(6):1196-203. PubMed ID: 709776 [Abstract] [Full Text] [Related]
16. Evaluation of two prediction models for digoxin dosing. Markantonis SL, Kyroudis A, Christopoulos T. Pharm World Sci; 1993 Feb 19; 15(1):29-33. PubMed ID: 8485504 [Abstract] [Full Text] [Related]
17. Pharmacokinetic prediction of serum digoxin concentration in the elderly. Mooradian AD, Wynn EM. Arch Intern Med; 1987 Apr 19; 147(4):650-3. PubMed ID: 3827452 [Abstract] [Full Text] [Related]
18. An assessment of population-based and Bayesian methods to individualize digoxin doses shortly after the start of therapy for atrial fibrillation. Chrystyn H, Dean S. J Clin Pharm Ther; 1991 Jun 19; 16(3):177-85. PubMed ID: 1869597 [Abstract] [Full Text] [Related]
19. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations. Lackner TE, Lau BW, Parvin C, Valdes R. Clin Pharm; 1988 Jun 19; 7(6):449-53. PubMed ID: 3402180 [Abstract] [Full Text] [Related]
20. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants. Ng PK, LeGatt D, Coates J, Collins-Nakai RL. Am J Hosp Pharm; 1985 Sep 19; 42(9):1977-9. PubMed ID: 3901741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]